Showing results (21-30 of 222) with videos related to
Sort By:
Pageof 23
Journal of Neurology, Neurosurgery, and Psychiatry|August 30, 2014
Sodium intake is associated with increased disease activity in multiple sclerosisMauricio F Farez, Marcela P Fiol, María I Gaitán, et al.Multiple Sclerosis International|August 30, 2014
Autoimmune disease prevalence in a multiple sclerosis cohort in ArgentinaMauricio F Farez, María E Balbuena Aguirre, Francisco Varela, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|June 1, 2026
Microbiome-derived metabolites from vitamin B2 and B9 pathways modulate MAIT cells from multiple sclerosis patientsJorge Correale, Mariano Marrodan, Maria A Piedrabuena, et al.Journal of the Neurological Sciences|September 24, 2014
Low familial risks for multiple sclerosis in Buenos Aires, ArgentinaMauricio F Farez, María E Balbuena Aguirre, Francisco Varela, et al.Journal of the International Neuropsychological Society : JINS|May 25, 2012
Alerting network dysfunction in early multiple sclerosisLucía Crivelli, Mauricio F Farez, Claudio D González, et al.Cytokine & Growth Factor Reviews|April 2, 2014
Integration of lectin-glycan recognition systems and immune cell networks in CNS inflammationSantiago P Mendez-Huergo, Sebastián M Maller, Mauricio F Farez, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|December 31, 2021
The frequency and characteristics of multiple sclerosis misdiagnosis in Latin America: A referral center study in Buenos Aires, ArgentinaMaría I Gaitán, Melanie Sanchez, Mauricio F Farez, et al.Frontiers in Neurology|July 11, 2018
Effects of Systolic Blood Pressure on Brain Integrity in Multiple SclerosisDaiana E Dossi, Hernán Chaves, Evelyn S Heck, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|April 30, 2026
Early use of high-efficacy disease-modifying therapies reduces the risk of progression independent of relapse and MRI activity in patients with relapsing-remitting multiple sclerosisMaría F Guarnaschelli, Mariano Marrodan, Braian E Sosa, et al.Annals of Clinical and Translational Neurology|June 10, 2025
Factors for Rituximab Refractoriness in AQP4-IgG+ NMOSD: A Cohort StudyMariano Marrodan, María A Piedrabuena, María A Zarate, et al.Pageof 23